Evidence mapPaperPMID 40269839Full record

SynthesisLipids in health and disease2025

Relationships of triglyceride-glucose-related indices with colorectal cancer incidence and mortality in an American population: a dose-response meta-analysis and cohort study.

Lan Luo, Zhu Liu, Quan Gan, Jing Feng, Lingyun Wang, Weiwei Ouyang

Abstract readMeta-Analysis
In one paragraph

Synthesis in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lan LuoDepartment of Hematology and Oncology, The First People's Hospital of Guiyang, Guiyang, Guizhou, 550002, China.
Zhu LiuDepartment of Gastrointestinal Surgery, The First People's Hospital of Guiyang, Guiyang, Guizhou, 550002, China.
Quan GanDepartment of Gastrointestinal Surgery, The First People's Hospital of Guiyang, Guiyang, Guizhou, 550002, China.
Jing FengDepartment of Hematology and Oncology, The First People's Hospital of Guiyang, Guiyang, Guizhou, 550002, China.
Lingyun WangDepartment of Hematology and Oncology, The First People's Hospital of Guiyang, Guiyang, Guizhou, 550002, China.
Weiwei OuyangDepartment of Oncology, The Affiliated Hospital of Guizhou Medical University and The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China. ouyangww103173@163.com.

Funding

a project financed by the Science and Technology Department of Guizhou Province [2014]7135the Affiliated Hospital and the Affiliated Cancer Hospital of Guizhou Medical University I-2020-22 and YJ2019
6 · The paper itself

Abstract

backgroundThe degree to which the triglyceride-glucose (TyG) index might interact with colorectal cancer (CRC) incidence and mortality is undefined. This systematic analysis was conducted through meta-analyses and large-scale databases.

methodsA meta-analysis was conducted through database search up to April 1, 2025, and articles investigating the incidence of CRC with clearly reported TyG index values, focusing on their dose-response relationship, were included. To validate the findings, data from the 1999-2018 National Health and Nutrition Examination Survey (NHANES) were utilized to explore links of TyG levels with CRC-linked mortality. Analyses involving restricted cubic splines (RCSs), weighted logistic regression (WLR), and multivariate Cox proportional hazards models were performed. Receiver operating characteristic (ROC) analyses explored predictive potential. Subgroup evaluation was subsequently conducted for detecting the susceptible populations.

resultsMultivariate logistic regression showcased a greater CRC incidence among individuals in quartiles two, three, and four of TyG and TyG-body mass index (TyG-BMI) (95% confidence intervals (CIs): 1.14-1.5, 1.07-1.45; 1.39-1.83, 1.11-1.64; and 1.60-2.12, 1.19-1.93, respectively; P < 0.001). In contrast, multivariate Cox regression indicated a significant increase in CRC-related mortality only in the second quartile of TyG (95% CI: 1.22-7.47; P < 0.05). Analysis of the RCS curves demonstrated that the incidence of CRC displayed a nonlinear association with TyG (P = 0.045 for nonlinearity) but a positive linear association with TyG-BMI (P = 0.385 for nonlinearity). The TyG and associated indices did not exhibit any obvious dose-response association with CRC-related mortality (P > 0.05). ROC analyses exploring CRC risk revealed that TyG-BMI outperformed all indicators (area under the curve (AUC) = 0.71). Subgroup analysis revealed statistically significant links of CRC incidence with both TyG-BMI and female sex.

conclusionTyG and TyG-BMI may function as dependable markers for predicting CRC likelihood, and TyG-BMI outperformed all other predictors considered herein. However, TyG and associated indices showed no significant interrelationships with the mortality of CRC.

Indexed as

Blood GlucoseColorectal NeoplasmsTriglyceridesAgedBody Mass IndexCohort StudiesFemaleHumansIncidenceMaleMiddle AgedNutrition SurveysProportional Hazards ModelsRisk FactorsROC CurveUnited StatesBlood GlucoseTriglyceridesColorectal neoplasmsIncidenceInsulin resistanceMeta-analysisMortalityNational health and nutrition examination surveyTriglyceride-glucose index

Identifiers

PMID40269839
PMCPMC12016320

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.